Lipigon Pharmaceuticals AB (publ) (FRA:9RP)

FRA:9RP Revenue

Lipigon Pharmaceuticals AB had revenue of 1.32M SEK in the twelve months ending September 30, 2025, down -85.32% year-over-year. In the year 2024, Lipigon Pharmaceuticals AB had annual revenue of 10.29M, down -37.30%.

• Revenue (ttm): 1.32M SEK
• Revenue Growth: -85.32%
• P/S Ratio: 3.74
• Revenue / Employee: 188.14K SEK
• Employees: 7
• Market Cap: 446.00K EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.29M	-6.12M	-37.30%
Dec 31, 2023	16.41M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	2.21M	-1.80M	-44.86%
Dec 31, 2020	4.01M	2.27M	130.20%